Research programme: obesity/diabetes therapy - Abbott
Alternative Names: Obesity/diabetes therapy research programme - AbbottLatest Information Update: 23 Jan 2013
At a glance
- Originator Abbott Laboratories
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetes mellitus; Obesity